Free Trial

TradeUP Acquisition (UPTDW) Competitors

$0.13 0.00 (-1.95%)
As of 05/1/2026

UPTDW vs. AIMDW, ALVOW, ACABW, RNA, and BFRIW

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Avidity Biosciences (RNA), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does TradeUP Acquisition compare to Ainos?

TradeUP Acquisition (NASDAQ:UPTDW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TradeUP AcquisitionN/AN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
TradeUP AcquisitionN/A N/A N/A
Ainos N/A N/A N/A

In the previous week, TradeUP Acquisition's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
TradeUP Acquisition Neutral
Ainos Neutral

Summary

Ainos beats TradeUP Acquisition on 1 of the 1 factors compared between the two stocks.

How does TradeUP Acquisition compare to Alvotech?

TradeUP Acquisition (NASDAQ:UPTDW) and Alvotech (NASDAQ:ALVOW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TradeUP AcquisitionN/AN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
TradeUP AcquisitionN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, TradeUP Acquisition's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
TradeUP Acquisition Neutral
Alvotech Neutral

Summary

Alvotech beats TradeUP Acquisition on 1 of the 1 factors compared between the two stocks.

How does TradeUP Acquisition compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and TradeUP Acquisition (NASDAQ:UPTDW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled TradeUP Acquisition'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
TradeUP Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
TradeUP Acquisition N/A N/A N/A

Summary

Atlantic Coastal Acquisition Corp. II and TradeUP Acquisition tied by winning 0 of the 0 factors compared between the two stocks.

How does TradeUP Acquisition compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and TradeUP Acquisition (NASDAQ:UPTDW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, Avidity Biosciences had 1 more articles in the media than TradeUP Acquisition. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for TradeUP Acquisition. Avidity Biosciences' average media sentiment score of 0.00 equaled TradeUP Acquisition'saverage media sentiment score.

Company Overall Sentiment
Avidity Biosciences Neutral
TradeUP Acquisition Neutral

TradeUP Acquisition has lower revenue, but higher earnings than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

Avidity Biosciences currently has a consensus target price of $69.42, suggesting a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Avidity Biosciences is more favorable than TradeUP Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32
TradeUP Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

TradeUP Acquisition has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. TradeUP Acquisition's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Avidity Biosciences-3,650.39% -44.92% -39.57%
TradeUP Acquisition N/A N/A N/A

Summary

Avidity Biosciences beats TradeUP Acquisition on 6 of the 9 factors compared between the two stocks.

How does TradeUP Acquisition compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and TradeUP Acquisition (NASDAQ:UPTDW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
TradeUP Acquisition N/A N/A N/A

In the previous week, Biofrontera had 1 more articles in the media than TradeUP Acquisition. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for TradeUP Acquisition. Biofrontera's average media sentiment score of 0.00 equaled TradeUP Acquisition'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
TradeUP Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$41.71MN/AN/AN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

Summary

Biofrontera beats TradeUP Acquisition on 2 of the 2 factors compared between the two stocks.

Get TradeUP Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPTDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPTDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPTDW vs. The Competition

MetricTradeUP AcquisitionBiological Products, Except Diagnostic Substances IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$359.01M$4.22B$11.77B
Dividend YieldN/AN/A5.87%5.26%
P/E RatioN/AN/A23.3727.07
Price / SalesN/A68.67155.5373.43
Price / CashN/AN/A52.0853.90
Price / BookN/A2.8137.876.69
Net IncomeN/A-$81.71M$114.66M$332.64M
7 Day Performance3.71%6.50%1.21%2.01%
1 Month PerformanceN/A5.53%5.50%9.19%
1 Year PerformanceN/AN/A18.68%39.59%

TradeUP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPTDW
TradeUP Acquisition
N/A$0.13
-2.0%
N/AN/A$0.00N/AN/A3
AIMDW
Ainos
N/A$0.09
+3.1%
N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
-18.2%
N/AN/A$0.00$586.32MN/A4
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15
RNA
Avidity Biosciences
1.322 of 5 stars
$12.99
+3.5%
$69.42
+434.4%
N/A$0.00$18.62MN/A190

Related Companies and Tools


This page (NASDAQ:UPTDW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners